A prescription for the US FDA for the regulation of health misinformation

被引：3
|
作者：
Kadakia, Kushal T. [1 ]
Beckman, Adam L. [1 ,2 ]
Krumholz, Harlan M. [3 ,4 ,5 ]
机构：
[1] Harvard Med Sch, Boston, MA USA
[2] Harvard Sch Business, Boston, MA USA
[3] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA
[4] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA
[5] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
来源：
NATURE MEDICINE | 2023年 / 29卷 / 03期
关键词：
D O I：
10.1038/s41591-022-02172-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The US Food and Drug Administration should address health misinformation through existing and new regulatory approaches, including modernizing product labeling, investing in infodemic surveillance and addressing the roles of the internet and social media.
引用
收藏
页码：525 / 527
页数：3
相关论文
共 50 条
  • [21] Autologous cell therapies: challenges in US FDA regulation
    McAltister, Todd N.
    Audley, David
    L'Heureux, Nicolas
    REGENERATIVE MEDICINE, 2012, 7 (06) : 94 - 97
  • [22] US drug regulation FDA ups pharma scrutiny
    Dorey, Emma
    CHEMISTRY & INDUSTRY, 2009, (16) : 6 - 6
  • [23] US FDA and industry reach agreement on Prescription Drug Fee User Act
    不详
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (14) : 1742 - 1742
  • [24] Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions
    Pamer, Carol A.
    Hammad, Tarek A.
    Wu, Yu-te
    Kaplan, Sigal
    Rochester, George
    Governale, Laura
    Mosholder, Andrew D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (02) : 158 - 174
  • [25] Prescription Stimulant Prescribing, Nonmedical Use, and Shortages US FDA Research and Response
    Rising, Joshua P.
    Califf, Robert M.
    JAMA PSYCHIATRY, 2025,
  • [26] Expanded FDA regulation of health and wellness apps
    Kasperbauer, T. J.
    Wright, David E.
    BIOETHICS, 2020, 34 (03) : 235 - 241
  • [27] Sunscreen: FDA regulation, and environmental and health impact
    Narla, Shanthi
    Lim, Henry W.
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2020, 19 (01) : 66 - 70
  • [28] Sunscreen: FDA regulation, and environmental and health impact
    Shanthi Narla
    Henry W. Lim
    Photochemical & Photobiological Sciences, 2020, 19 : 66 - 70
  • [29] The FDA's regulation of health economic information
    Neumann, PJ
    Claxton, K
    Weinstein, MC
    HEALTH AFFAIRS, 2000, 19 (05) : 129 - 137
  • [30] US FDA issues public health advisory on phenylpropanolamine
    Reactions Weekly, 2000, 827 (1) : 2 - 2
12345